Benefits
Highest Consistent Bioavailability
CCM has shown 35-42% bioavailability in multiple human studies — consistently higher than other calcium forms across diverse populations and methodologies. Distinguished from simple calcium citrate or calcium malate by being a specific compound salt (not physical blend) with unique solubility characteristics.
Bone Mineral Density in Adolescents (Foundational Trial)
Lloyd et al. 1993 JAMA — adolescent girls receiving CCM had significantly higher peak bone mass accumulation vs placebo. Important developmental trial. Johnston et al. 1992 NEJM showed similar BMD increases in children.
Postmenopausal Bone Health
Multiple RCTs in postmenopausal women show CCM + vitamin D modestly reduces bone loss vs placebo. Effect sizes modest; foundational evidence for calcium + vitamin D combination.
Acid-Independent Absorption
Like calcium citrate, CCM does not require stomach acid for dissolution — works in PPI users, elderly, post-bariatric surgery.
Beverage Fortification
CCM is the calcium form used in calcium-fortified orange juice (Tropicana Pure Premium with calcium, etc.) and other fortified beverages — providing well-absorbed dietary calcium.
Mechanism of action
Compound Salt vs Physical Blend
CCM is NOT a simple physical mixture of calcium citrate + calcium malate — it is a specific compound salt (e.g., hexa-calcium dicitrate trimalate) with unique X-ray diffraction pattern, higher solubility, and distinct dissolution kinetics from the individual salts.
Enhanced Solubility
CCM has higher aqueous solubility than either calcium citrate or calcium malate alone — basis for superior bioavailability.
Citrate + Malate Synergy
Both citrate and malate can chelate calcium and enhance solubility. The compound salt structure maximizes calcium availability across the GI tract.
Standard Calcium Functions
Once absorbed, calcium serves bone mineralization (hydroxyapatite), muscle contraction, neurotransmitter release, blood clotting, and signaling — same as calcium from any source.
Clinical trials
RCT of CCM (~500 mg elemental calcium/day) vs placebo in 94 healthy adolescent girls for 18 months. Outcomes: bone mineral density.
94 adolescent girls aged 11-12.
CCM significantly increased BMD vs placebo. Important developmental data — peak bone mass attained in adolescence influences osteoporosis risk decades later. Foundational trial for adolescent calcium fortification.
RCT of CCM (1,000 mg elemental calcium/day) vs placebo in 71 pairs of identical twins for 3 years.
Pre-pubertal and pubertal twins.
CCM-supplemented twins had significantly higher BMD increase vs placebo twins, particularly in pre-pubertal subgroup. Twin design controls genetic factors. Strong evidence for calcium adequacy during growth.
About this ingredient
Calcium citrate malate (CCM) is a SPECIFIC COMPOUND SALT of calcium with both citrate AND malate anions — NOT a simple physical blend of calcium citrate + calcium malate. The compound salt has a distinct X-ray diffraction pattern, higher solubility, and superior bioavailability vs either component alone. Elemental calcium content: ~26% by weight.
KEY EVIDENCE: CCM has shown 35-42% bioavailability in human studies — among the HIGHEST CONSISTENTLY ACHIEVED across calcium supplement forms. Lloyd 1993 JAMA and Johnston 1992 NEJM provide foundational evidence for CCM in adolescent and pediatric bone mass development. Used in branded supplements (Citracal Plus®) and calcium-fortified beverages (Tropicana Pure Premium with calcium and many others).
EVIDENCE-BASED USES: (1) Pediatric/adolescent bone mass development (Lloyd 1993, Johnston 1992); (2) Postmenopausal bone health adjunct; (3) Calcium supplementation in PPI users (acid-independent absorption); (4) Beverage and food fortification; (5) Premium calcium supplementation when bioavailability is priority.
CRITICAL CAUTIONS: (1) ALUMINUM ABSORPTION — citrate enhances aluminum absorption; caution in CKD/dialysis with aluminum-containing drugs; (2) DOSE LIMITS — calcium absorption maxes at ~500 mg single dose; divide doses; UL 2,500 mg/day total; (3) DRUG INTERACTIONS — same general calcium interactions; separate from chelated drugs by 2-4 hours; (4) HYPERCALCEMIA at chronic very high doses; (5) KIDNEY STONES — calcium oxalate stone-formers should consult urology; CCM's citrate component is theoretically protective but megadose calcium could overwhelm; (6) THIAZIDE DIURETICS — hypercalcemia risk; (7) PREGNANCY/LACTATION — calcium supplementation safe; (8) COST — CCM is intermediate between carbonate (cheapest) and bisglycinate (most expensive); good value for evidence-based bioavailability; (9) For PPI USERS, calcium citrate, calcium citrate malate, and calcium bisglycinate are all reasonable acid-independent options; (10) The 'fortified calcium beverages are as good as supplements' claim is largely SUPPORTED for CCM-fortified beverages — the compound salt is bioavailable in liquid form.